Zobrazeno 1 - 10
of 12
pro vyhledávání: '"G. James Morgan"'
Autor:
François Taillard, G. James Morgan, Uma Mahadevan, Wayne Langholff, R. Nissinen, Brian G. Feagan, Bruce Salzberg, William J. Sandborn, Russell D. Cohen, Michael Safdi, Gary R. Lichtenstein
Publikováno v:
American Journal of Gastroenterology. 113:1678-1688
We described pregnancy outcomes in Crohn’s disease (CD) patients enrolled in the TREAT Registry who received infliximab before, or during pregnancy and those not treated with infliximab or any biologic agent. In the TREAT Registry (1999–2012), pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ae42b56aab8704e255e38e37024b787
https://doi.org/10.1038/s41395-018-0202-9
https://doi.org/10.1038/s41395-018-0202-9
Autor:
Proton Rahman, Alice B. Gottlieb, Lluís Puig, Christopher T. Ritchlin, Yin You, Michael Song, G. James Morgan, Shelly Kafka, Iain B. McInnes, Arthur Kavanaugh
Publikováno v:
The Journal of rheumatology. 46(11)
Objective.Evaluate enthesitis, physical function, and health-related quality of life (HRQOL) among patients with psoriatic arthritis (PsA) who are naive to anti–tumor necrosis factor agents.Methods.In PSUMMIT 1 and 2, patients with PsA were randomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b233714c9a36453d1a4f222a6ee78b7b
https://pubmed.ncbi.nlm.nih.gov/30936281
https://pubmed.ncbi.nlm.nih.gov/30936281
Autor:
G. James Morgan, Sergio Schwartzman
Publikováno v:
Arthritis Research & Therapy
The tumor necrosis factor (TNF) antagonists are parenterally administered biologic response modifiers indicated for the management of rheumatoid arthritis. Although infliximab, etanercept, and adalimumab are all members of this class, they differ in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8878cc2a8e180d06cf0de69ad928708a
http://europepmc.org/articles/PMC2833461
http://europepmc.org/articles/PMC2833461
Publikováno v:
Arthritis & Rheumatism. 48:864-866
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ef3f0b0854c2d898ff941627ce75f29
https://doi.org/10.1002/art.10781
https://doi.org/10.1002/art.10781
Publikováno v:
Arthritis Research & Therapy
Tumor necrosis factor (TNF) antagonists have dramatically improved the outcomes of rheumatoid arthritis (RA). Three agents currently available in the USA – infliximab, etanercept, and adalimumab – have been designed to modify the biologic effects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89515229f01b56be542dbc207d55369b
https://doi.org/10.1186/ar1013
https://doi.org/10.1186/ar1013
Publikováno v:
The American journal of medicine. 95(2A)
In a randomized, open-label, controlled, multicenter, 12-week study, the efficacy and safety of nabumetone (1,000-2,000 mg/day) versus diclofenac (100-200 mg/day), naproxen (500-1,500 mg/day), ibuprofen (1,200-3,200 mg/day), or piroxicam (10-20 mg/da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c789b7e19be3aa0dde07942479521bd3
https://pubmed.ncbi.nlm.nih.gov/8356998
https://pubmed.ncbi.nlm.nih.gov/8356998
Publikováno v:
Muscle & Nerve. 4:137-140
A patient with rheumatoid arthritis who developed multiple mononeuropathies multiplex was shown to have vasculitis in nerve biopsy, but no evidence of inflammatory muscle disease in muscle biopsy. Treatment with penicillamine caused the rare complica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a84f6338e36e61f68d4dc3b773d49142
https://doi.org/10.1002/mus.880040210
https://doi.org/10.1002/mus.880040210
Publikováno v:
American Journal of Otolaryngology. 5:258-261
Two patients with Cogan's syndrome had acute bilateral hearing loss and vestibular dysfunction. Interstitial keratitis was discovered by slit-lamp examination. Both cases responded to corticosteroid treatment. Immediate recognition of this syndrome a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ccb51cd0f1505808204afcee05e08f3
https://doi.org/10.1016/s0196-0709(84)80035-6
https://doi.org/10.1016/s0196-0709(84)80035-6
Autor:
Jacques R. Caldwell, P.Kahler Hench, I. Jon Russell, William Lages, Stephen G. Pauker, Andrew Chalmers, Claire Bombardier, Charles Ludivico, Peter H. Schur, Thomas H. Taylor, Michael O'Hanlan, James H. Ware, George W. Torrance, William A. Arnold, Martin G. Larson, J.Leighton Read, G. James Morgan, Barbara J. McNeil, Mark E. Thompson, Robert M. Bennett, Robert P. Sheon, Matthew H. Liang
Publikováno v:
The American Journal of Medicine. 81:565-578
In a six-month, randomized, double-blind study at 14 centers, auranofin (3 mg twice daily) was compared with placebo in the treatment of patients with classic or definite rheumatoid arthritis. All patients had unremitting disease for at least the pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3de523de1123e7d9c103b3aff10cf2ea
https://doi.org/10.1016/0002-9343(86)90539-5
https://doi.org/10.1016/0002-9343(86)90539-5
Autor:
Robert M. Levin, Gilbert Levinson, Paula L. Stillman, Vivien S. Emmel, Harry L. Greene, David Levenson, Thomas Ebert, Janice L. Willms, Joel Caslowitz, Bryson Ley, G. James Morgan, Thomas Parrino, Hamolsky Mw, David B. Swanson, Charles Hatem, Sydney Smee, Stephen H. Robinson, Alfred E. Stillman
Publikováno v:
Annals of Internal Medicine. 105:762
Current techniques do not provide a reproducible, reliable, or valid basis for assessing clinical skills. The need for large-scale direct observation and standardized assessment procedures has precluded development of better techniques. A project usi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27143e7a700518aa038b7a63a6b082c3
https://doi.org/10.7326/0003-4819-105-5-762
https://doi.org/10.7326/0003-4819-105-5-762